Aeterna Zentaris Releases AEZS-108 Safety, Efficacy Data
Aeterna Zentaris said that AEZS-108 is in a Phase 2 trial conducted in Europe by the German AGO Study Group (Study AGO-GYN5), in advanced ovarian and endometrial cancer,
BeOne Medicines is set to invest $300m in expanding its manufacturing and research operations at the Princeton West Innovation Campus in Hopewell, New Jersey, US.
Pro-Pointer said that Coenzyme-A Technologies is into the application of new technology to the formulation and manufacture of a series of proprietary products which address nutritional deficiencies that